Abstract:OBJECTIVE:To investigate the pathologic and clinical characteristics of patients with liver dysfunction after allogeneic hemopoietic stem cell transplantation (Allo-HSCT), and evaluate the role of liver biopsy in diagnosis and management of liver dysfunction post Allo-HSCT.METHODS:Ten patients with hematological diseases, 5 males and 5 females, aged 34.5 (15-56), underwent Allo-HSCT, 6 receiving Allo-HSCT from their HLA-matched siblings, one receiving haploidentical transplant, two receiving cord blood transplantation from sibling, and one receiving unrelated BMT. The conditioning regimens included Cy/TBI (in 2 cases), and non-TBI regimen (in 8 cases). All the patients received cyclosporine A, short term MTX and MMF for the prophylaxis of graft-versus-host disease (GVHD). Test of liver function and examination of HBV and HCV related serologic markers were performed for the patients and recipients before transplantation and for those who had liver dysfunction after transplantation. Percutaneous liver biopsy was performed for these 10 patients. Biopsy specimens were examined histologically by hematoxylin-eosin staining, Masson staining and immunohistochemical stating of related viruses.RESULTS:All 10 patients showed liver dysfunction on average 3.5 months (2-5 months) after the transplantation. Seven patients positive in HBV and HCV serologic markers before HSCT remained positive after the transplantation. Three patients negative in HBV/HCV markers before and after Allo-HSCT were diagnosed as with GVHD clinically. Eight patients had other manifestations of chronic GVHD. Eight patients received liver biopsy 5.5 months (4-12 months) because of poor improvement in the initial treatment stage. The result of biopsy showed hepatic GVHD in 3 patients and hepatic GVHD concomitant with HBV or HCV hepatitis reactivation in 7 patients. The liver function of 3 patients diagnosed as with hepatic GVHD returned to normal after the use of the second-line anti-GVHD therapy. The other 7 patients used anti-virus agents combined with immunosuppressive agents with the result that 2 patients remained alive with normal liver function and 5 patients died due to pulmonary complication (2 cases) or hepatic failure and hepatic coma (3 cases).CONCLUSION:Liver biopsy is of distinguished diagnostic value for patients with refractory hepatic GVHD after Allo-HSCT. The prognosis is poor for patients having hepatic GVHD concomitant with active hepatic virus infection. At this time the role of liver biopsy is limited and management should be made according to the clinical features and liver pathology.

CT Evaluation of Acute Graft-Versus-Host Disease-Mediated Lung Injury Following Allogenic Hematopoietic Stem Cell Transplantation

Imaging Features of Chest CT and Prognosis of Proven Pulmonary Invasive Fungal Disease After Hematopoietic Stem Cell Transplantation

[Effect of Graft-Versus-host Disease on Relapse and Survival in 100 Patients after Allogeneic Hematopoietic Stem Cell Transplantation].

Cytokine expressions in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Imaging Diagnosis of Cytomegalovirus Pneumonitis after Kidney Transplantation

The role of colonoscopy in diagnosis of gastrointestinal graft-versus-host disease and cytomegalovirus colitis after allergenic hematopoietic stem cell transplantation

[Exploration of Acute Graft Versus Host Disease and Its Risk Factors after Allo-Hematopoietic Stem Cell Transplantation].

Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation

The effects of different body positions of low-dose expiratory phase spiral CT on the diagnosis of pulmonary air trapping after stem cell transplantation

Relationship between CD4+CD25+regulatory T cells and graft-versus-host disease after allogeneic haematogenesis stem cell transplantation

The Predictive Value of Pulmonary Function Test Before Transplantation for Chronic Pulmonary Graft-Versus-host-disease after Allogeneic Hematopoietic Stem Cell Transplantation

Research on the Key T Cells and Cytokines of Agvhd after Allogeneic Hematopoietic Stem Cell Transplantation

Diagnosis and Treatment of Graft Versus Host Disease after Liver Transplantation

Primary graft dysfunction; possible evaluation by high resolution computed tomography, and suggestions for a scoring system

Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: Report of six cases

Liver Biopsy in the Management of Liver Dysfunction after Allogeneic Hematopoietic Stem-Cell Transplantation

Application of CD25 and CTLA4 gene transcription levels in early prediction of acute graft-versus-host disease

Clinical characteristics of acute graft-versus-host disease among different donors of allogeneic hematopoietic stem cell transplantation.

Health Related Quality of Life among Patients with Chronic Graft-Versus-host Disease in China.

Application of MSCT Post-Processing Techniques in Pulmonary Infections after Kidney Transplantation

Risk Factors for Acute Graft-Versus-Host Disease after Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Center Experience.